Search This Blog

Monday, December 30, 2019

Auris forms new unit focused on tinnitus and hearing loss

Auris Medical (EARS +12.2%announces a new subsidiary, Zilentin Ltd., under which it will bundle its development projects in tinnitus (ringing in the ears) and hearing loss. The unit will be domiciled in Zug, Switzerland.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.